CCTV+: Lyrics of White Peony Root into the Air
BEIJING, Nov. 3, 2022 /PRNewswire/ -- Located in southeast China, Jiangxi is ringed on three sides by mountains, bordering rivers and lakes on the north. Mountains and hills undulate in the region, with large basins scattering in the middle. The complex and diverse terrain, is a cradle for a variety of plants. The humid and hot monsoon climate safeguards their...
DOUBLE HONORS FOR AMGEN WITH GREAT PLACE TO WORK™ CERTIFICATIONS FOR BOTH ITS SINGAPORE ENTITIES IN 2022
SINGAPORE, Nov. 3, 2022 /PRNewswire/ -- Amgen announced both its entities in Singapore - Amgen Singapore Manufacturing (ASM) and its commercial affiliate Amgen Biotechnology Singapore (ABS), have been awarded Great Place to Work® certifications in the 'medium and large' workplace category for 2022. This is the fourth consecutive certification for ASM and...
First SEA Genomic Data Digitisation Collaboration Formed to Improve Cancer Clinical Trial Access
SINGAPORE, Nov. 3, 2022 /PRNewswire/ -- Oncoshot has just announced one of its biggest collaborations to date with Icon Cancer Centre in Singapore, alongside Roche. Together the partners plan to facilitate more comprehensive genomic profiling data to increase access to more trial options for cancer patients. This first-ever collaboration in SEA will...
First in-human use of OncoRes Medical’s cancer imaging system successful
Quantitative Micro-Elastography (QME) Imaging System published in peer reviewed Cancer Research PERTH, Australia, Nov. 3, 2022 /PRNewswire/ -- OncoRes Medical today announces positive data from the first in-cavity use of its Quantitative Micro-Elastography (QME) Imaging System. The study, titled Quantitative micro-elastography enables in vivo detection of residual cancer in the surgical cavity during breast-conserving surgery was published in Cancer...
Turn Biotechnologies Names 25-year Biotech Industry Veteran Richard Peterson Chief Financial Officer
Seasoned Executive has Successful Track Record Working with Global Investors to Raise Billions of Dollars MOUNTAIN VIEW, Calif., Nov. 2, 2022 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced it has appointed Richard "Ric" Peterson as chief financial officer. ...
Antengene Announces IND Approval for the Phase I STAMINA-001 Study to Evaluate ATG-037 (CD73 Inhibitor) for the Treatment of Locally Advanced or Metastatic Solid Tumors in China
- ATG-037, an inhouse asset developed by Antengene and with global rights, has been approved to enter clinical studies in Australia and China, thus becoming the first oral small molecule CD73 inhibitor entering the clinical-stage in China and the wider Asia Pacific region. ATG-037 IND in Australia has been started enrolling in...
Everise Named to Inc.’s Inaugural Power Partner Awards
Roundup highlights B2B partners that support startups across all business functions and empower growth PLANTATION, Fla., Nov. 2, 2022 /PRNewswire/ -- Inc. Business Media today announced the inaugural Power Partner Awards, honoring B2B organizations across the globe that have proven track records supporting entrepreneurs and helping startups grow. Everise, one of the fastest...
Shanghai Operation Robot announced the first Robot-assisted human clinical trial of biliary stent placement surgery
SHANGHAI, Nov. 2, 2022 /PRNewswire/ -- Shanghai Operation Robot Co.,Ltd announced the results of its initial clinical trial of ERCP (Endoscopic retrograde cholangiopancreatography) robot in biliary stent placement surgery. It is the first Robot-assisted human clinical trial of biliary stent placement surgery in the world. The surgery was conducted by Aopeng Medical. The operation was performed...
Dr Amit Kakar joins MedGenome Board of Directors
The company has also added Navjeewan Khosla from Novo Holdings as Board Observer. The company had announced a $50 million Series D investment led by Novo Holdings in August 2022. BANGALORE, India, Nov. 2, 2022 /PRNewswire/ -- MedGenome is a leading provider of genomic solutions for populations in South Asia and provides advanced genetic testing and bioinformatics...
NCCN Working with Medlive to Advance High-Quality Cancer Care in China and Worldwide
United States-based National Comprehensive Cancer Network enters strategic cooperation agreement with Chinese medical information website to publish and translate evidence-based expert consensus guidelines for cancer care; now available at nccnchina.org.cn. PLYMOUTH MEETING, Pa., Nov. 2, 2022 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United...
